Catapano Joseph Ronald 4

What Happened

• Joseph Catapano, Chief Accounting Officer of Teladoc Health, reported a conversion of 2,083 restricted stock units into 2,083 shares on Apr 1, 2026, and a subsequent sale of 675 shares on Apr 2, 2026 at $5.11 per share for total proceeds of about $3,452. The conversion is recorded under Form 4 code M (exercise/conversion of a derivative) and the sale under code S (open market sale). Footnotes indicate the conversion was of RSUs (one-for-one) and that the sale was to cover tax withholding.

Key Details

• Transaction dates & prices:
  • Apr 1, 2026: 2,083 RSUs converted to 2,083 shares (code M; $0 cost basis shown for the conversion) — F1/F3.
  • Apr 2, 2026: 675 shares sold at $5.11 each for ~$3,452 (code S) — F2.
• Shares owned after the transaction: not disclosed in this Form 4 filing.
• Notable footnotes:
  • F1: RSUs convert one-for-one to common stock.
  • F2: Shares sold to cover tax withholding on RSU vesting.
  • F3: The RSU grant (25,000 RSUs on Oct 1, 2024) vests one-third at the first anniversary and the remainder in eight substantially equal quarterly installments — 2,083 matches a quarterly installment.
• Filing timeliness: Form filed Apr 3, 2026; transactions occurred Apr 1–2, 2026. The filing appears timely.

Context

• This was a routine post-vesting transaction: restricted stock units converted to shares, and a portion of those shares sold to cover tax withholding. Such "sell to cover" transactions are common after vesting and are not the same as a discretionary sell signal about company prospects. No purchases were reported.